Johnson & Johnson stock (NYSE: JNJ) lost about 7% in 2024, underperforming the broader S&P 500 index, which gained 23% for ...

NEW YORK, NY / ACCESSWIRE / January 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Johnson & ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Aaron Taylor Johnson's highly anticipated 28 Years Later has dropped another new look at the film as it nears its release.

Among the Dow Jones Industrial Average's 30 components, there are two historically cheap brand-name companies, as well as a ...

UK Biobank has today announced the launch of the world’s most comprehensive study of the proteins circulating in our bodies, which will transform the study of diseases and their treatments.

Southfield-based PharmaCo Inc. — a cannabis company linked to a bribery scheme to Michigan’s then-top marijuana regulator ...

Bryan Johnson, the founder of Braintree and subject of a new Netflix doc, is on a quest for remarkable longevity.

When the BIOSECURE Act hit a setback and missed the chance of becoming law in 2024, the deceleration of the draft legislation ...

As September came to a close, health care stocks had returned about 12% in 2024. But from that point through mid-December, S&P 500 health care stocks plummeted in value as investo ...

Johnson & Johnson offers safer payouts and stronger growth. Discover why JNJ stock is the better dividend option compared to ...

Dwayne Johnson now holds a greater stake in WWE, the place where his journey began. As AFROTECH™ previously reported, the ...